Testing Tislelizumab Plus Capecitabine for Biliary Cancer
In the ever-evolving landscape of cancer therapy, biliary tract cancers (BTC) remain a formidable challenge due to their aggressive nature ...
In the ever-evolving landscape of cancer therapy, biliary tract cancers (BTC) remain a formidable challenge due to their aggressive nature ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine